ABSTRACT
No other public health cancer prevention tool has made more of a difference than the PAP smear. Since the introduction of the Papanicoulau (Pap) smear in 1941, this screening tool has reduced the incidence of cervical cancer in the United States by 75% and the death rate continues to decline by 4% a year [1]. Cervical cancer is one of the few cancers with well-dened precancerous stages, allowing for successful treatment with early detection and diagnosis [2-3].
